Vincent Peterkin

1.4k total citations · 1 hit paper
10 papers, 818 citations indexed

About

Vincent Peterkin is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Vincent Peterkin has authored 10 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Vincent Peterkin's work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (3 papers) and Computational Drug Discovery Methods (3 papers). Vincent Peterkin is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (3 papers) and Computational Drug Discovery Methods (3 papers). Vincent Peterkin collaborates with scholars based in United States, Belgium and United Kingdom. Vincent Peterkin's co-authors include J. Andrew Williams, Theunis C. Goosen, Susan Hurst, Dennis A. Smith, Ruth Hyland, Jeffrey R. Koup, S. Ball, Barry Jones, Jonathan Bauman and Scott P. Myrand and has published in prestigious journals such as British Journal of Clinical Pharmacology, Drug Metabolism and Disposition and Advances in experimental medicine and biology.

In The Last Decade

Vincent Peterkin

10 papers receiving 788 citations

Hit Papers

DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SU... 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Peterkin United States 7 563 315 252 131 119 10 818
Stephen Fowler Switzerland 22 560 1.0× 314 1.0× 321 1.3× 149 1.1× 111 0.9× 47 1.1k
Hayley S. Brown United Kingdom 12 772 1.4× 478 1.5× 295 1.2× 194 1.5× 118 1.0× 18 1.3k
Brian Ethell United Kingdom 16 458 0.8× 299 0.9× 376 1.5× 76 0.6× 185 1.6× 26 1.1k
Imad Hanna United States 20 660 1.2× 520 1.7× 283 1.1× 154 1.2× 187 1.6× 30 1.1k
Jan L. Wahlstrom United States 22 729 1.3× 354 1.1× 348 1.4× 187 1.4× 159 1.3× 47 1.3k
Jairam Palamanda United States 19 339 0.6× 223 0.7× 252 1.0× 94 0.7× 92 0.8× 35 968
Michael Zientek United States 18 671 1.2× 310 1.0× 485 1.9× 208 1.6× 81 0.7× 32 1.1k
Kenneth J. Ruterbories United States 14 438 0.8× 290 0.9× 211 0.8× 78 0.6× 133 1.1× 37 990
Takafumi Iwatsubo Japan 18 688 1.2× 524 1.7× 264 1.0× 153 1.2× 140 1.2× 33 1.2k
Upendra A. Argikar United States 19 478 0.8× 310 1.0× 406 1.6× 117 0.9× 258 2.2× 55 1.2k

Countries citing papers authored by Vincent Peterkin

Since Specialization
Citations

This map shows the geographic impact of Vincent Peterkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Peterkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Peterkin more than expected).

Fields of papers citing papers by Vincent Peterkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Peterkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Peterkin. The network helps show where Vincent Peterkin may publish in the future.

Co-authorship network of co-authors of Vincent Peterkin

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Peterkin. A scholar is included among the top collaborators of Vincent Peterkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Peterkin. Vincent Peterkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bolleddula, Jayaprakasam, Robert S. Jones, Priyanka Kulkarni, et al.. (2024). Establishing a physiologically based pharmacokinetic framework for aldehyde oxidase and dual aldehyde oxidase‐CYP substrates. CPT Pharmacometrics & Systems Pharmacology. 14(1). 164–178. 1 indexed citations
2.
Bolleddula, Jayaprakasam, Lionel Cheruzel, Robert S. Jones, et al.. (2023). Challenges and Opportunities for In Vitro–In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation. Drug Metabolism and Disposition. 51(12). 1591–1606. 6 indexed citations
3.
Randolph, John T., Tongmei Li, A. Chris Krueger, et al.. (2020). Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(7). 126986–126986. 3 indexed citations
4.
Kikuchi, Ryota, Vincent Peterkin, William J. Chiou, Sonia M. de Morais, & Daniel A.J. Bow. (2016). Validation of a total IC50 method which enables in vitro assessment of transporter inhibition under semi-physiological conditions. Xenobiotica. 47(9). 825–832. 11 indexed citations
5.
Peterkin, Vincent, et al.. (2015). A High Throughput, 384-Well, Semi-Automated, Hepatocyte Intrinsic Clearance Assay for Screening New Molecular Entities in Drug Discovery. Combinatorial Chemistry & High Throughput Screening. 18(5). 442–452. 9 indexed citations
6.
Cai, Hongliang, Nghia Nguyen, Vincent Peterkin, et al.. (2010). A Humanized UGT1 Mouse Model Expressing the UGT1A1*28 Allele for Assessing Drug Clearance by UGT1A1-Dependent Glucuronidation. Drug Metabolism and Disposition. 38(5). 879–886. 37 indexed citations
7.
Peterkin, Vincent, Jonathan Bauman, Theunis C. Goosen, et al.. (2007). Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes. British Journal of Clinical Pharmacology. 64(4). 458–468. 46 indexed citations
8.
Bauman, Jonathan, Theunis C. Goosen, Meera Tugnait, et al.. (2005). UDP-GLUCURONOSYLTRANSFERASE 2B7 IS THE MAJOR ENZYME RESPONSIBLE FOR GEMCABENE GLUCURONIDATION IN HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition. 33(9). 1349–1354. 16 indexed citations
9.
Williams, J. Andrew, Ruth Hyland, Barry Jones, et al.. (2004). DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS. Drug Metabolism and Disposition. 32(11). 1201–1208. 687 indexed citations breakdown →
10.
Peterkin, Vincent, et al.. (1991). Effect of Growth Conditions on the Extracellular Production of the Aspartic Proteinase by Candida Albicans. Advances in experimental medicine and biology. 306. 265–267. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026